For millennia, the human brain has been a largely unexplored frontier. Relative to the whole of human history, studying, understanding, and influencing human thought and consciousness is a radically new endeavor. Only in the twenty-first century has science truly begun to progress far enough into the field of neuroscience for effective neurotechnologies to begin to take shape.
The implications of neurotechnologies for society are vast. From pharmaceuticals that improve quality of life, to brain imaging that revolutionizes our conception of human consciousness, neurotechnologies stand to change our understanding of ourselves and harness the power of the brain and nervous systems myriad functions to promote human thriving.
Although the layperson might not be familiar with the term neurotechnology, in fact these emerging technologies already affect many peoples everyday lives. Neurotechnologies have become widespread in medical contexts, but other uses are on the horizon.
Neurotechnology refers to any technology that provides greater insight into brain or nervous system activity, or affects brain or nervous system function. Neurotechnology can be used purely for research purposes, such as experimental brain imaging to gather information about mental illness or sleep patterns. It can also be used in practical applications to influence the brain or nervous system; for example, in therapeutic or rehabilitative contexts.
Broadly speaking, neurotechnology uses neural interfaces to read or write information into the central nervous system (CNS), the peripheral nervous system (PNS), or the autonomic nervous system (ANS). There are a number of methods to do this, both invasive and noninvasive.
Neurotechnologies fall into the following three categories:
Neurotechnology is already being practically applied in the medical and wellness industries, with many future implications for other contexts including education, workplace management, national security, and even sports. The following are some of the most prominent uses of neurotechnologies today:
Outside the field of neurotechnology, Pharmaceuticals are the most common form of neuro treatment in everyday life. They influence brain chemistry by modulating chemicals and hormones within the brain in situations where the subjects brain does not produce normal amounts of these chemicals on its own. Pharmaceuticals can help treat mental conditions such as depression and anxiety. Cell therapies are another emerging field. Cell therapy seeks to use stem cells to induce the brain to produce new cells in order to heal brain damage or disorders.
Research and development of neurotechnologies has the potential to change the human experience in multiple ways. These technologies could open a number of doors to enhanced mental and physical ability, once researchers are able to overcome neurotechnologys current limitations.
Currently, the greatest potential of neurotechnologies is in their ability to alleviate human suffering through enabling better treatments for mental and neurological disorders, movement disorders and sensory disorders. Innumerable people could benefit from treatments for as-yet unsolved neurological disorders like Alzheimers Disease and multiple sclerosis, as well as psychiatric disorders like bipolar disorder and phobias.
Beyond medical applications, neurotechnologies have the potential to elevate human experience and functioning in other ways. For example, these technologies could enhance human learning ability, boost physical performance, and enable efficiencies like brain-controlled devices.
In the future, neurotechnologies could potentially affect almost everyone in society at large. They could be used in applications like the following:
Neuromodulation technology, neuroprostheses technology, and BMI technology currently only have the capability to gather data over time. There is very limited continuous sensing, with limited means of modifying stimulation to the nervous system as needed based on neurofeedback.
This means neurotechnologies are, as yet, unable to perform autonomously and in synthesis with brain signals. Further research and development is needed in order to create a smooth-running closed-loop system that allows the technology to read, write, and modify brain signals simultaneously.
In many ways, neurotechnology is still in its infancy. Yet there is already great potential to use these technologies to positively influence brain activity for a variety of reasons, from disorder treatment and management to accelerated learning.
Although not a neurotechnology, pharmaceuticals are currently the most widely used therapy, with their ability to affect brain chemistry through blocking or stimulating the production of certain hormones that affect mood or cognition.
MRIs and other brain imaging technologies have provided researchers with important brain mapping information. These technologies are also used in clinical settings to measure brain activity based on blood flow or electromagnetic current.
Other neurotechnologies, such as neuromodulation technology, neuroprostheses technology, and BMI technology, have so far provided a rudimentary ability to read and write nervous system activity. However, these technologies require much development before they can be widely used in medical or other applications.
Researchers are currently working on closed-loop neurotechnology systems that can treat neurological, psychiatric and movement disorders. These systems may be able to restore physical movement after an injury or disease of the brain, provide neuroprosthetics or implants to cure neurological disorders like Parkinsons disease, treat memory disorders such as Alzheimers disease or dementia, and relieve psychiatric disorders that reduce quality of life.
Neurotechnology researchers are also focused on creating closed-loop technologies for general consumer applications. For example, next-generation neurotechnologies may be able to speed learning and information retention.
Neurotechnologies with better sensor capabilities are currently in development. Better sensors are important for two reasons: they will have the ability to generate immediate neurofeedback, and they will facilitate better understanding of the downstream effects of stimulation. This will aid researchers in developing more accurate models of how information travels downstream.
In addition, stimulation technologies currently have limited spatial and temporal selectivity. Researchers are currently developing stimulation technologies that can instantly respond to neurofeedback and self-modify as needed.
Overall, researchers are modifying closed-loop neurotechnology systems to be more responsive and autonomous so they can work in tandem with the subjects brain, responding to neurofeedback fluidly.
Since neurotechnologies affect the brainthe center of human consciousnessconsidering ethical and legal questions around agency is paramount. The ethics and legality of neurotechnology still has far to go, and must be a prime consideration moving forward.
Since neurotechnologies have to do with modifying human brain and nervous system activity, there are a number of ethical questions involved. In particular, potential subjects must be informed of the risks of neurotechnologies. Some neurotechnologies, such as intracranial electrode implantationplacing electrodes inside the skull in order to monitor seizureshold a high risk for the subject.
It is essential that researchers and clinicians communicate transparently with subjects in order to create realistic expectations for studies and procedures. In addition, subjects must have a realistic understanding of the potential benefits of a study or procedure for themselves or others.
Finally, neurotechnologies have the potential to influence or change a persons thought patterns or behavior, thus potentially influencing their essential identity. Neurotechnology researchers must weigh this potential to affect identity against the benefits of improved functioning or quality of life.
Safety and reliability are essential considerations when discussing the legal implications of neurotechnologies. Further research is needed in order to establish baseline parameters and expectations for minimal tissue damage, safe implementation techniques, and long-term safety in the use of neurotechnologies. It is also important to know if a device is performing as intended, and provide options to override the technology as needed. Researchers should be aware of these potential issues and consider them during product development.
In addition, data management is an important legal consideration in the neurotechnology field. There does not yet exist a standardized system for data security and privacy, such as guidelines for ownership of patient information, access to such data, and data sharing. Such a system needs to be developed in order to best stay in compliance with the law.
Although neurotechnologies come with ethical and legal risks, many researchers believe their potential to improve quality of life for millions or billions around the globe indicates that the benefits are likely to outweigh the risks.
For instance, in 2014 the National Institutes of Health (NIH) launched its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative on the basis that neurotechnologies have the potential to launch a quantum leap in the understanding of brain function and disease. The NIH states its belief that this could facilitate more effective treatments for neurological, mental, and even substance abuse disorders among the global population.
Neurotechnology holds incredible potential to improve many aspects of human life, from treating debilitating diseases to improving efficiency, learning potential, and even physical prowess. However, neurotechnologies are still a relatively young development, and much is yet unknown about their full capabilities, as well as the ethical, legal, and societal implications they may have for society going forward.
To learn more about neurotechnologies, how they work, their applications, and future possibilities, we invite you to read the IEEE Brain white paper Future Neural Therapeutics.
Interested in becoming an IEEE member? Joining this community of over 420,000 technology and engineering professionals will give you access to the resources and opportunities you need to keep on top of changes in technology, as well as help you get involved in standards development, network with other professionals in your local area or within a specific technical interest, mentor the next generation of engineers and technologists, and so much more.
Read more:
Neurotechnologies: The Next Technology Frontier | IEEE Brain
- Opinion | The Fight for Your Kids' Brains Has Already Begun - The New York Times - September 9th, 2023 [September 9th, 2023]
- DEFENDING THE BRAIN | Duke Mag - Duke University - September 9th, 2023 [September 9th, 2023]
- The Innovations and Success of Elon Musk - OPP.Today - September 9th, 2023 [September 9th, 2023]
- Top Companies Using AI to Transform the Healthcare Industry ... - Cryptopolitan - September 9th, 2023 [September 9th, 2023]
- UN Warns Unregulated Neurotechnology Threatens 'Freedom of Thought' - Yahoo News - July 23rd, 2023 [July 23rd, 2023]
- I felt like there was someone in my head, and it wasn't me. - UNESCO - July 23rd, 2023 [July 23rd, 2023]
- Unraveling Connections Between the Brain and Gut - The Good Men Project - July 23rd, 2023 [July 23rd, 2023]
- Neurotechnology: what it is, applications - Iberdrola - February 10th, 2023 [February 10th, 2023]
- Forget Media Manipulation And Misinformation via TikTok And Twitter, Neurotechnology Heralds The New Battle For Our Brains - Forbes - February 10th, 2023 [February 10th, 2023]
- The Jacob Laboratory Translational Neurotechnology - January 2nd, 2023 [January 2nd, 2023]
- Massachusetts Institute Of Technology Experts Come Together In A Play Inspired By Advances In Neurotechnology - India Education Diary - January 2nd, 2023 [January 2nd, 2023]
- Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders ... - November 19th, 2022 [November 19th, 2022]
- Research Experience for Undergraduates | Center for Neurotechnology - November 8th, 2022 [November 8th, 2022]
- Axoft Launches Brain Implant Technology to Treat Long-Term Neurological Disorders and is Granted FDA Breakthrough Device Designation - Business Wire - October 19th, 2022 [October 19th, 2022]
- Researcher combines AI and microelectronics to create neural implants that fight brain disorders - University of Toronto - October 19th, 2022 [October 19th, 2022]
- Global Contactless Biometrics Technology Market Size And Forecast | Aware Inc., Fingerprint Cards AB, Fujitsu Limited, Gemalto N.V., HID Global,... - October 19th, 2022 [October 19th, 2022]
- Facial Recognition Market Size and Share 2022 | Global Industry Analysis, Feasibility Study and Development Scope by 2032 | NEC Corporation (NEC)... - October 17th, 2022 [October 17th, 2022]
- Pitt scientists awarded $8 million for neurotechnology to restore arm and hand movements after strokes - University of Pittsburgh - October 15th, 2022 [October 15th, 2022]
- UN: Highlights from the 51st Session of the Human Rights Council - ARTICLE 19 - Article 19 - October 15th, 2022 [October 15th, 2022]
- PD Neurotechnology, a MedTech start-up for patients suffering from ... - October 8th, 2022 [October 8th, 2022]
- Brain ScienceConsciousness as the Property of Thought | Neurotech - VGR.com - October 6th, 2022 [October 6th, 2022]
- Facial Recognition Technology Market to witness a substantial growth owing to rising adoption of technology till 2032 | NEC Corporation, Aware,... - October 6th, 2022 [October 6th, 2022]
- ARC Future Fellowships awarded to Turner Institute researchers - Monash University - September 17th, 2022 [September 17th, 2022]
- Critics Picks: Cate Blanchett, Steven Spielberg Films Among the 15 Best of the Fall Festivals - Hollywood Reporter - September 17th, 2022 [September 17th, 2022]
- Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting - Business Wire - September 17th, 2022 [September 17th, 2022]
- If separating conjoined twins results in death, which one should die? - Big Think - September 17th, 2022 [September 17th, 2022]
- Theater of Thought Review: Werner Herzog Crafts a Bracing Exploration of Neurotechnology and Consciousness - Hollywood Reporter - September 7th, 2022 [September 7th, 2022]
- Elon Musk seeks to expand his empire in the world of neurotechnology - Gearrice - September 7th, 2022 [September 7th, 2022]
- VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimers Disease - Yahoo Finance - September 7th, 2022 [September 7th, 2022]
- Tri-anim Health Services announces exclusive relationship to distribute BrainScope's breakthrough technology for mild head injury including... - September 7th, 2022 [September 7th, 2022]
- Interaxon Inc. (Muse) Highlights Myndlifts Preliminary Study and the Benefit of Partnerships for Digital Therapeutics Research - BioSpace - September 7th, 2022 [September 7th, 2022]
- Elon Musk and Neuralink executive Shivon Zilis reportedly conceived twins via IVF - The Independent - August 29th, 2022 [August 29th, 2022]
- Biometric Wearable Market Research Insights with Trends, Competitive Analysis, Opportunities, Forecast 2022 to 2030 Muleskinner - Muleskinner - August 29th, 2022 [August 29th, 2022]
- Neurotechnology - the future of the legal profession? - Lexology - August 25th, 2022 [August 25th, 2022]
- Future criminals could be monitored by chips in their brains, experts claim... - The US Sun - August 25th, 2022 [August 25th, 2022]
- Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference - GuruFocus.com - August 25th, 2022 [August 25th, 2022]
- Investing in Brain Research and Neuroengineering - University of Houston - August 2nd, 2022 [August 2nd, 2022]
- Hamilton-based Zentrela working to understand the cannabis experience - Hamilton Spectator - August 2nd, 2022 [August 2nd, 2022]
- IntualityAI may be Able to Provide Psychotherapy for Robots in Future - AZoRobotics - August 2nd, 2022 [August 2nd, 2022]
- Coconuts, Corporations: On Vauhini Vara's The Immortal King Rao - lareviewofbooks - August 2nd, 2022 [August 2nd, 2022]
- MindMaze Enters New Strategic Partnership with Alfa Romeo F1 Team ORLEN to Advance Technologies for Brain Health, Safety, and Performance - Yahoo... - July 13th, 2022 [July 13th, 2022]
- MindMaze Receives Recognition as one of Switzerland's Best Managed Companies - Business Wire - July 13th, 2022 [July 13th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - July 11th, 2022 [July 11th, 2022]
- Three top technologies taking healthcare by storm - Kalkine Media - July 11th, 2022 [July 11th, 2022]
- It is time to leverage technology to correct the challenges people have with their minds: Antano Solar, CE.. - ETHealthWorld - July 11th, 2022 [July 11th, 2022]
- Elon Musk Secretly Fathered Twins With His Company's Executive: Report - KFI AM 640 - July 11th, 2022 [July 11th, 2022]
- Stryker to host conference call on July 26, 2022 - GuruFocus.com - July 11th, 2022 [July 11th, 2022]
- Neurotechnology Announces MOSIP Integration and Support in MegaMatcher SDK and ABIS - PR Newswire - June 15th, 2022 [June 15th, 2022]
- Musk's Twitter $44 Billion Bid Includes Financier Close to Russia - Report By Investing.com - Investing.com - June 15th, 2022 [June 15th, 2022]
- Stryker Strengthens Its R&D Capabilities with Advanced Global Technology Center - Press Trust of India - Press Trust of India - June 9th, 2022 [June 9th, 2022]
- Cuba is the only nation with a governmental science and technology program on the brain - Granma English - June 9th, 2022 [June 9th, 2022]
- 3 Disruptive Tech Stocks to Go All In on Now - InvestorPlace - June 9th, 2022 [June 9th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - PR Newswire - June 5th, 2022 [June 5th, 2022]
- 3D Reconstruction Technology Market Size, Scope and Forecast | 3D Reconstruction, Eos Systems Inc., Everest Innovation Technology, Microsoft, NAVVIS,... - June 5th, 2022 [June 5th, 2022]
- Fingerprint Biometrics in the VAR Market to Eyewitness Massive Growth by 2031 The Greater Binghamton Business Journal - The Greater Binghamton... - June 5th, 2022 [June 5th, 2022]
- Horrors of Elon Musks Neuralink REVEALED including brain hacking technology and animal deaths... - The Scottish Sun - May 25th, 2022 [May 25th, 2022]
- Stryker Co. (NYSE:SYK) Receives Consensus Rating of Buy from Brokerages - Defense World - May 25th, 2022 [May 25th, 2022]
- Evon Medics, LLC Has Been Awarded $2.8 Million Grant for the Development and Evaluation of its Mobile Health Platform for Remote Management of... - May 11th, 2022 [May 11th, 2022]
- Mobile Biometrics Market Analysis by Size, Business Strategies, Share, Growth, Trends, Revenue, Competitive Landscape and Developments Forecast by... - May 11th, 2022 [May 11th, 2022]
- Dubai on the Brain: NeuroVigil's Philip Low Assembles ... - May 6th, 2022 [May 6th, 2022]
- Research Associate: Participatory Research and Communications Officer job with KINGS COLLEGE LONDON | 292429 - Times Higher Education - May 6th, 2022 [May 6th, 2022]
- Face Recognition Software Market 2022: Size, Industry Share, Approaches, and Forecast By 2028, (Idemia (FR), Aware (US), Leidos (US), BioID (DE)) ... - May 6th, 2022 [May 6th, 2022]
- Stocktake: Investors wary on Musk's Twitter deal - The Irish Times - May 6th, 2022 [May 6th, 2022]
- Hydrocolloid Dressing Market Competitive Landscape Analysis With Forecast by 2027 - BioSpace - May 6th, 2022 [May 6th, 2022]
- Futuristics Overview of Neural Control Market: Industry Insights and Forecast 2022-2028 by MIT, Hebrew university, Haier, Neurotechnology,,, and more... - May 3rd, 2022 [May 3rd, 2022]
- Brain Computer Interface (BCI) Market Poised to Garner a Valuation of USD 5.48 Billion by 2030, Growing at a 14.72% CAGR - Report by Market Research... - May 3rd, 2022 [May 3rd, 2022]
- Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery... - May 3rd, 2022 [May 3rd, 2022]
- Stryker to participate in the Bank of America Securities 2022 Health Care Conference - Benzinga - Benzinga - May 3rd, 2022 [May 3rd, 2022]
- Earnings week 2: Supply chain shortages slowed ResMed, other medtechs from meeting demand - MedTech Dive - May 3rd, 2022 [May 3rd, 2022]
- Mind-reading technology Are we ready for it? - Freethink - April 25th, 2022 [April 25th, 2022]
- The brain implant that can translate your thoughts into text - SBS News - April 15th, 2022 [April 15th, 2022]
- Stryker says 88 jobs to be eliminated in May, part of previously announced layoff schedule - The Ledger - April 15th, 2022 [April 15th, 2022]
- Moon Rabbit Collaborates with Foresight Institute to Speed Up Life Extension Research - CryptoNewsZ - April 4th, 2022 [April 4th, 2022]
- Cybin Announces Initiation of Kernel Flow Feasibility Study Measuring Psychedelic Effects on the Brain - Business Wire - April 4th, 2022 [April 4th, 2022]
- Restoring touch through electrodes implanted in the human brain will require engineering around a sensory lag - The Conversation Indonesia - March 31st, 2022 [March 31st, 2022]
- Carry On: From ketamine-assisted therapy to neurofeedback training, here's how to take a trip without leaving B.C. - BCBusiness - March 31st, 2022 [March 31st, 2022]
- Omniscient Neurotechnologys Quicktome Platform Wins 2022 ... - March 18th, 2022 [March 18th, 2022]
- Applied neuroscience needs a task force to craft effective governance - STAT - March 18th, 2022 [March 18th, 2022]
- It Can Take Weeks for Some Patients With Severe COVID to Recover Consciousness - HealthDay News - March 18th, 2022 [March 18th, 2022]
- Global Neural Control Market 2022 Outlook and COVID-19 Impact Prediction 2028 MIT, Hebrew university, Haier, Neurotechnology The Bite - The Bite - March 18th, 2022 [March 18th, 2022]